Viewing Study NCT03067935


Ignite Creation Date: 2025-12-24 @ 10:10 PM
Ignite Modification Date: 2026-03-05 @ 3:30 AM
Study NCT ID: NCT03067935
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2018-05-21
First Post: 2017-02-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Individual Patient Expanded Access-Glembatumumab Vedotin
Sponsor: Celldex Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module